Sign inGet started

Davis Thomas Andrew

Insider CIK 1338185 · GNCA CHIEF MEDICAL OFFICER · CLDX Sr. VP & CMO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GNCA GENOCEA BIOSCIENCES, INC. S Sale2022-04-042022-04-051,091$1.25 $1.4K68,330SEC↗
GNCA GENOCEA BIOSCIENCES, INC. S Sale2022-03-162022-03-172,717$1.10 $3.0K69,421SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2022-03-152022-03-1793,750— $093,750SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award2022-03-152022-03-1731,250— $072,138SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2021-03-152021-03-1793,750— $093,750SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2021-03-152021-03-17100,000— $0100,000SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award2021-03-152021-03-1731,250— $031,250SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2020-06-012020-06-0224,938— $024,938SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award2020-06-012020-06-026,623— $06,623SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2020-04-022020-04-0646,313— $046,313SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award2020-04-022020-04-0612,299— $012,299SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2019-02-072019-02-11300,000— $0300,000SEC↗
GNCA GENOCEA BIOSCIENCES, INC. A Award deriv2018-10-012018-10-02500,000— $0500,000SEC↗
CLDX Celldex Therapeutics, Inc. A Award deriv2017-06-152017-06-16150,000— $0150,000SEC↗
CLDX Celldex Therapeutics, Inc. A Award deriv2016-06-082016-06-09157,000— $0157,000SEC↗
CLDX Celldex Therapeutics, Inc. A Award deriv2015-06-102015-06-11116,500— $0116,500SEC↗
CLDX Celldex Therapeutics, Inc. A Award deriv2014-06-042014-06-05116,500— $0116,500SEC↗
CLDX Celldex Therapeutics, Inc. A Award deriv2013-07-012013-07-03115,000— $0115,000SEC↗
CLDX Celldex Therapeutics, Inc. A Award deriv2012-09-122012-09-13115,000— $0115,000SEC↗